eli lilly mounjaro news - Search News

Eli Lilly, Food and Drug Administration

The Washington Post · 2d

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

Barron's on MSN · 3d

Eli Lilly’s Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers.

Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer in shortage, according to the Food and Drug Administration.It’s a sign that pharmaceutical firm Lilly is making strides to improve the supply issues that have plagued the sector.

YAHOO!Finance · 2d

Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list

GLP-1 weight-loss drugs Mounjaro and Zepbound have been removed from the Food and Drug Administration's (FDA) shortage list. Senior Health Reporter Anjalee Khemlani reports more on the story and what it means for competitors,

NHS England proposes phased rollout for Eli Lilly's star obesity drug

While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...

4don MSN

Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline

Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer's disease, ALS and other brain ...

3d

Mounjaro and Zepbound no longer in shortage

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

2d

England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access

NHS England plans a phased rollout of tirzepatide to treat severe obesity, with early trials showing significant weight loss.

3d

Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

2d

Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant

The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results